The National Health Technology Assessment System (SiNATS) has contributed over the last decade to improving access to medicines, promoting the sustainability of the SNS and reducing waste, but ...

NANJING, China and GAITHERSBURG, Md., June 27, 2025 /PRNewswire/ -- TransThera Sciences Inc. ('TransThera') announced that the translational studies of tinengotinib in CCA with acquired resistance to ...

DelveInsight's Anti-CCR8 Antibodies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory ...

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025; Marks the ...

Regulators and manufacturers advance biosimilars for aflibercept, omalizumab, and dupilumab, enhancing access to treatment in ...

Jaguar Health (JAGX) announced that the company plans to pursue approval from the European Medicines Agency’s Committee for Veterinary Medicinal Products for Canalevia in the European Union for ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine, as published in Frontiers in Science, could ...

MDNA11 Phase 1/2 clinical trial on track for data readouts in second half of the year as a single agent and in combination with KEYTRUDA ® at medical conferences and a planned KOL event MDNA11 ...